Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2025-12-24 @ 5:18 PM
NCT ID:
NCT00100750
Brief Title:
Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer
Official Title:
Gemcitabine and R115777 Combination Therapy for Metastatic Breast Cancer
Study:
NCT00100750
Protocol Section:
NCT00100750